trending Market Intelligence /marketintelligence/en/news-insights/trending/rwjpjdablvpgd_6p6x75mq2 content esgSubNav
In This List

Anteo Diagnostics extends interim CEO's appointment

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Anteo Diagnostics extends interim CEO's appointment

Anteo Diagnostics Ltd. said Christopher Parker will remain as the company's interim CEO until June 30, 2019.

In April, Parker was appointed to the interim CEO post for an initial three-month period.

The contract extension will provide business continuity as the company executes its development strategy in the battery and diagnostic markets.

Australia-based Anteo Diagnostics is engaged in the development and commercialization of products for the life sciences, clinical diagnostics and bioseparations sectors.